Literature DB >> 22335601

Characterization of critical physical and mechanical properties of freeze-dried grape powder for development of a clinical patient delivery system.

Daniel Hu1, Rahul V Haware, Mazen L Hamad, Kenneth R Morris.   

Abstract

Grapes are hypothesized to be a "food medicine." Freeze-dried grape powder (FDGP) is being used to test clinical activity for a variety of applications and a reproducible and reliable delivery system was required. The FDGP was characterized using traditional physico-chemical methods to generate the data needed to identify its primary liability, i.e. moisture sorption. Above a threshold level of moisture content (~25% w/w, at RT), the material becomes both difficult to handle and exhibits significant degradation of several potentially clinically important chemical components (catechin, epicatechin, resveratrol). A moisture sorption isotherm was then used to tie the threshold to the exposure relative humidity above which this occurs. Kinetic uptake studies were used to estimate the maximum safe exposure time at a given humidity (a square root time dependence of moisture uptake was observed). Armed with this knowledge, a FDGP compact coated with a compression coat [100% bees wax or combinations of carnauba wax (70%) with HPC (30%) or Avicel(®) PH 102 (30%) or lactose monohydrate (30%)] was developed that will insure the shelf life of the material without the need for special handling for approximately more than 3 months.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22335601     DOI: 10.3109/10837450.2012.659257

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  2 in total

1.  Protective effects of a grape-supplemented diet in a mouse model of retinal degeneration.

Authors:  Amit K Patel; Ashley Davis; Maria Esperanza Rodriguez; Samantha Agron; Abigail S Hackam
Journal:  Nutrition       Date:  2015-10-28       Impact factor: 4.008

2.  Physico-Mechanical Properties of Coprocessed Excipient MicroceLac® 100 by DM(3) Approach.

Authors:  Rahul V Haware; Joseph P Kancharla; Aishwarya K Udupa; Scott Staton; Mali R Gupta; Antoine Al-Achi; William C Stagner
Journal:  Pharm Res       Date:  2015-06-09       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.